Best Penny Stocks Under 50 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.50 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.50. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Tilray NASDAQ:TLRY$0.41 +0.01 (+2.17%) As of 06/4/2025 04:00 PM EasternTilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. More about TilrayMarket Capitalization$411.76 millionP/E Ratio-1.36Consensus RatingHoldConsensus Price Target$1.92 (+368.5% Upside)Volume29.78 million sharesAverage Volume28.59 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Sangamo Therapeutics NASDAQ:SGMO$0.49 -0.01 (-1.64%) As of 06/4/2025 04:00 PM EasternSangamo Therapeutics, Inc, a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. More about Sangamo TherapeuticsMarket Capitalization$114.72 millionP/E Ratio-0.66Consensus RatingModerate BuyConsensus Price Target$4.50 (+814.6% Upside)Volume3.20 million sharesAverage Volume8.77 million shares3. WW International NASDAQ:WW$0.25 -0.03 (-10.51%) As of 05/15/2025WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW InternationalMarket Capitalization$20.04 millionP/E Ratio-0.04Consensus RatingHoldConsensus Price Target$2.25 (+801.4% Upside)Volume10.45 million sharesAverage Volume10.83 million shares4. Sunnova Energy International NYSE:NOVA$0.20 -0.01 (-3.49%) As of 06/4/2025 03:58 PM EasternSunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$25.35 millionP/E Ratio-0.06Consensus RatingHoldConsensus Price Target$4.36 (+2,060.2% Upside)Volume4.83 million sharesAverage Volume10.92 million shares5. Plus Therapeutics NASDAQ:PSTV$0.35 -0.03 (-6.91%) As of 06/4/2025 04:00 PM EasternPlus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus TherapeuticsMarket Capitalization$6.00 millionP/E Ratio-0.14Consensus RatingModerate BuyConsensus Price Target$11.50 (+3,160.6% Upside)Volume4.56 million sharesAverage Volume5.25 million shares6. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$6.00 (+3,178.7% Upside)Volume36.66 million sharesAverage Volume9.57 million shares7. Cellectar Biosciences NASDAQ:CLRB$0.46 +0.18 (+66.32%) As of 06/4/2025 04:00 PM EasternCellectar Biosciences, Inc, a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. More about Cellectar BiosciencesMarket Capitalization$21.28 millionP/E Ratio-0.27Consensus RatingHoldConsensus Price Target$12.50 (+2,607.4% Upside)Volume623.93 million sharesAverage Volume3.67 million shares8. EON Resources NYSEAMERICAN:EONR$0.43 +0.04 (+10.97%) As of 06/4/2025 04:10 PM EasternEON Resources Inc, an independent oil and natural gas company, focuses on the acquisition, development, exploration, and production of oil and natural gas properties in the Permian Basin. More about EON ResourcesConsensus RatingBuyConsensus Price Target$2.00 (+365.1% Upside)Volume2.40 million sharesAverage Volume3.21 million sharesToday's Range$0.37▼$0.4450-Day Range$0.35▼$0.539. GlycoMimetics NASDAQ:GLYC$0.21 +0.00 (+0.48%) As of 06/4/2025 04:00 PM EasternGlycoMimetics, Inc, a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. More about GlycoMimeticsMarket Capitalization$13.55 millionP/E Ratio-0.46Consensus RatingModerate BuyVolume302,013 sharesAverage Volume6.42 million sharesToday's Range$0.20▼$0.2210. Applied Therapeutics NASDAQ:APLT$0.38 +0.02 (+5.45%) As of 06/4/2025 04:00 PM EasternApplied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. More about Applied TherapeuticsMarket Capitalization$53.15 millionP/E Ratio-0.23Consensus RatingModerate BuyConsensus Price Target$6.10 (+1,524.9% Upside)Volume1.25 million sharesAverage Volume3.36 million shares11. Harvard Bioscience NASDAQ:HBIO$0.41 -0.01 (-2.56%) As of 06/4/2025 04:00 PM EasternHarvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. More about Harvard BioscienceMarket Capitalization$18.14 millionP/E Ratio-1.24Consensus RatingModerate BuyConsensus Price Target$3.00 (+631.2% Upside)Volume3.58 million sharesAverage Volume2.98 million shares12. Brand Engagement Network NASDAQ:BNAI$0.43 +0.02 (+3.83%) As of 06/4/2025 04:00 PM EasternBrand Engagement Network, Inc provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. More about Brand Engagement NetworkMarket Capitalization$18.33 millionConsensus RatingBuyConsensus Price Target$6.00 (+1,283.8% Upside)Volume4.55 million sharesAverage Volume2.77 million sharesToday's Range$0.39▼$0.4713. Abpro NASDAQ:ABP$0.21 0.00 (-1.31%) As of 06/4/2025 04:00 PM EasternAbpro Holdings Inc is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. More about AbproMarket Capitalization$12.84 millionConsensus RatingBuyConsensus Price Target$4.00 (+1,793.9% Upside)Volume590,707 sharesAverage Volume5.56 million sharesToday's Range$0.21▼$0.2214. Canoo NASDAQ:GOEV$0.34 -0.07 (-15.95%) Closing price 01/28/2025Extended Trading$0.34 0.00 (0.00%) As of 01/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canoo Inc, a mobility technology company, designs, develops, markets, and manufactures electric vehicles for consumer, commercial fleet, government, and military customers in the United States. More about CanooMarket Capitalization$1.67 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$23.50 (+6,731.4% Upside)Volume6.24 million sharesAverage Volume3.34 million shares15. Vaxart NASDAQ:VXRT$0.40 -0.01 (-3.07%) As of 06/4/2025 04:00 PM EasternVaxart, Inc, a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. More about VaxartMarket Capitalization$92.20 millionP/E Ratio-0.99Consensus RatingBuyConsensus Price Target$3.00 (+642.6% Upside)Volume1.89 million sharesAverage Volume2.44 million shares16. bioAffinity Technologies NASDAQ:BIAF$0.30 +0.02 (+7.22%) As of 06/4/2025 04:00 PM EasternbioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. More about bioAffinity TechnologiesMarket Capitalization$8.47 millionP/E Ratio-0.37Consensus RatingHoldConsensus Price Target$6.00 (+1,880.2% Upside)Volume1.36 million sharesAverage Volume3.21 million shares17. Mersana Therapeutics NASDAQ:MRSN$0.37 +0.02 (+5.79%) As of 06/4/2025 04:00 PM EasternMersana Therapeutics, Inc, a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. More about Mersana TherapeuticsMarket Capitalization$45.99 millionP/E Ratio-0.60Consensus RatingBuyConsensus Price Target$5.20 (+1,309.2% Upside)Volume1.21 million sharesAverage Volume2.60 million shares18. Aethlon Medical NASDAQ:AEMD$0.37 +0.02 (+4.37%) As of 06/4/2025 04:00 PM EasternAethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. More about Aethlon MedicalMarket Capitalization$5.87 millionP/E Ratio-0.23Consensus RatingBuyConsensus Price Target$7.00 (+1,815.7% Upside)Volume99,061 sharesAverage Volume2.27 million shares19. Cognition Therapeutics NASDAQ:CGTX$0.31 0.00 (-0.74%) As of 06/4/2025 04:00 PM EasternCognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition TherapeuticsMarket Capitalization$19.07 millionP/E Ratio-0.32Consensus RatingBuyConsensus Price Target$5.63 (+1,728.7% Upside)Volume647,727 sharesAverage Volume2.66 million shares20. Affimed NASDAQ:AFMD$0.18 -0.10 (-34.95%) As of 05/19/2025Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. More about AffimedMarket Capitalization$2.92 millionConsensus RatingHoldConsensus Price Target$7.90 (+4,251.5% Upside)Volume22.99 million sharesAverage Volume4.24 million sharesToday's Range$0.17▼$0.2421. LeddarTech NASDAQ:LDTC$0.34 +0.00 (+1.46%) As of 06/4/2025 04:00 PM EasternLeddarTech Holdings Inc provides AI-based fusion and perception software solutions for advanced driver assistance solutions and autonomous driving applications in Canada. More about LeddarTechMarket Capitalization$9.78 millionP/E Ratio-0.11Consensus RatingModerate BuyConsensus Price Target$3.00 (+782.6% Upside)Volume96,564 sharesAverage Volume2.11 million shares22. Biodesix NASDAQ:BDSX$0.30 0.00 (-1.46%) As of 06/4/2025 04:00 PM EasternBiodesix, Inc operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. More about BiodesixMarket Capitalization$43.41 millionP/E Ratio-0.76Consensus RatingModerate BuyConsensus Price Target$1.75 (+490.8% Upside)Volume1.20 million sharesAverage Volume2.33 million shares23. Origin Materials NASDAQ:ORGN$0.48 +0.03 (+6.63%) As of 06/4/2025 04:00 PM EasternOrigin Materials, Inc, together with its subsidiaries, operates as a carbon-negative materials company. The company develops a proprietary biomass conversion platform to convert biomass, or plant-based carbon into building block chemicals chloromethylfurfural and hydrothermal carbon, as well as other oils and extractives and other co-products. More about Origin MaterialsMarket Capitalization$71.66 millionP/E Ratio-0.84Consensus RatingSellConsensus Price Target$1.50 (+213.9% Upside)Volume611,044 sharesAverage Volume1.43 million shares24. 23andMe NASDAQ:ME$0.50 -0.27 (-35.32%) Closing price 03/28/2025Extended Trading$0.50 0.00 (0.00%) As of 03/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. More about 23andMeMarket Capitalization$13.36 millionP/E Ratio-0.03Consensus RatingSellVolume29.28 million sharesAverage Volume1.35 million sharesToday's Range$0.60▼$1.1025. OrangeKloud Technology NASDAQ:ORKT$0.46 -0.01 (-1.50%) As of 06/4/2025 03:58 PM EasternOrangekloud Technology, Inc is a holding company, which engages in providing information technology consulting services. Its digital transformation projects include the sales and consulting of Microsoft Dynamics ERP software licenses. More about OrangeKloud TechnologyMarket Capitalization$10.86 millionConsensus RatingBuyConsensus Price Target$5.00 (+975.3% Upside)Volume64,223 sharesAverage Volume1.43 million sharesToday's Range$0.45▼$0.48 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Robinhood Stock Keeps Giving Investors Reasons To Buy CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Intuit's AI Boom: Stock Soaring, But Should Investors Hit Pause? Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Analog Devices' Cyclical Recovery Story Has Just Begun Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
